VBI Vaccines Inc.

VBI Vaccines Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.93
Market Cap
$93.06 M
Shares Outstanding
97.66 M
Public Float
78.16 M

Profile

Address
222 3rd Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.vbivaccines.com
Updated 07/08/2019
VBI Vaccines, Inc. is a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. Its pipeline includes Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

Financials

View All

Jeffrey Baxter
President, Chief Executive Officer & Director
Tomer Kariv
Director